Search

Your search keyword '"Huiqin Chen"' showing total 345 results

Search Constraints

Start Over You searched for: Author "Huiqin Chen" Remove constraint Author: "Huiqin Chen" Language undetermined Remove constraint Language: undetermined
345 results on '"Huiqin Chen"'

Search Results

1. Deacidification of Acidic Oil Catalyzed by Sulfonated Mesoporous Silica for Biodiesel Production: Optimization, Kinetic, and Enhancement by Using Calcined Kaolin

4. Advancements of Lutein Extraction from Microalgae Biomass: A Review

5. 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

8. Supplementary Data from Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor

10. Data from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

14. Data from Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor

15. Supplementary Figure from Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor

17. Overview of Named Entity Recognition

20. Abstract PD11-06: Radiomics model based on magnetic resonance image compilation (MagIC) as early predictor of pathologic complete response to neoadjuvant systemic therapy in triple-negative breast cancer

21. Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo

22. Prediction model of interfacial heat transfer coefficient changing with time and ingot diameter

25. Supplementary Figure-5 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

26. Data from Rapamycin Regulates Stearoyl CoA Desaturase 1 Expression in Breast Cancer

27. Data from Differences in Gene and Protein Expression and the Effects of Race/Ethnicity on Breast Cancer Subtypes

29. Supplementary Figure 3 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

30. Supplementary Data from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

31. Supplementary Table-11 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

32. Supplementary Table-10 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

33. Supplementary Table-3 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

34. Supplementary Figures 1-3 from Differences in Gene and Protein Expression and the Effects of Race/Ethnicity on Breast Cancer Subtypes

35. Data from Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer

39. Supplementary Fig 1 from Weekly nab-Rapamycin in Patients with Advanced Nonhematologic Malignancies: Final Results of a Phase I Trial

41. Data from Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer

42. Supplementary Table-7 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

43. Data Supplement from Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer

44. Data from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

45. Data from PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

46. Supplementary Figure-6 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

47. Data from Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer

48. Supplementary Table-2 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

49. Supplementary Table-8 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

Catalog

Books, media, physical & digital resources